The enigmatic ear: Unveiling a rare case of a primary cutaneous CD8+ acral T-cell lymphoproliferative disorder with a literature review.

IF 0.9 Q4 ONCOLOGY Rare Tumors Pub Date : 2023-09-22 eCollection Date: 2023-01-01 DOI:10.1177/20363613231204046
Ghada Sahraoui, Farah Sassi, Lamia Charfi, Raoudha Doghri, Karima Mrad
{"title":"The enigmatic ear: Unveiling a rare case of a primary cutaneous CD8+ acral T-cell lymphoproliferative disorder with a literature review.","authors":"Ghada Sahraoui,&nbsp;Farah Sassi,&nbsp;Lamia Charfi,&nbsp;Raoudha Doghri,&nbsp;Karima Mrad","doi":"10.1177/20363613231204046","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction:</b> Primary cutaneous CD8+ acral T-cell lymphoproliferative disorder (CD8+ ATCLPD) is a rare form of cutaneous T-cell lymphoma that commonly presents on the acral regions of the body. We report a case of a 61-year-old man diagnosed with primary cutaneous CD8+ ATCLPD of the ear. <b>Case presentation:</b> A 61-year-old man presented with a non-healing, erythematous painful macule on the ear that had been evolving for the past 3 months. The lesion was resected, and histopathological examination revealed a primary cutaneous CD8+ ATCLPD with acral localization. Further investigations including CT scan of the thorax, abdomen and pelvis were done to stage the disease. The results showed no extracutaneous involvement. <b>Conclusion:</b> Accurate identification of primary cutaneous CD8+ ATCLPD is crucial due to its distinct prognostic and therapeutic implications compared to other CD8+ cytotoxic lymphoid proliferations. Primary cutaneous CD8+ ATCLPD can be treated conservatively and typically follows a slow clinical course, regardless of the treatment method. Understanding the clinical context, as well as the morphological and immunophenotypic characteristics, can assist in making a precise diagnosis.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2023-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b3/87/10.1177_20363613231204046.PMC10517602.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rare Tumors","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20363613231204046","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Primary cutaneous CD8+ acral T-cell lymphoproliferative disorder (CD8+ ATCLPD) is a rare form of cutaneous T-cell lymphoma that commonly presents on the acral regions of the body. We report a case of a 61-year-old man diagnosed with primary cutaneous CD8+ ATCLPD of the ear. Case presentation: A 61-year-old man presented with a non-healing, erythematous painful macule on the ear that had been evolving for the past 3 months. The lesion was resected, and histopathological examination revealed a primary cutaneous CD8+ ATCLPD with acral localization. Further investigations including CT scan of the thorax, abdomen and pelvis were done to stage the disease. The results showed no extracutaneous involvement. Conclusion: Accurate identification of primary cutaneous CD8+ ATCLPD is crucial due to its distinct prognostic and therapeutic implications compared to other CD8+ cytotoxic lymphoid proliferations. Primary cutaneous CD8+ ATCLPD can be treated conservatively and typically follows a slow clinical course, regardless of the treatment method. Understanding the clinical context, as well as the morphological and immunophenotypic characteristics, can assist in making a precise diagnosis.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
神秘的耳朵:揭示一例罕见的原发性皮肤CD8+肢端T细胞淋巴增生性疾病的文献综述。
简介:原发性皮肤CD8+肢端T细胞淋巴增生性疾病(CD8+ATLPD)是一种罕见的皮肤T细胞淋巴瘤,通常出现在身体肢端区域。我们报告了一例61岁的男性,被诊断为耳朵原发性皮肤CD8+ACLPD。病例介绍:一名61岁的男子在过去3个月里,耳朵上出现了一个无法愈合的红斑疼痛性黄斑。病变被切除,组织病理学检查显示原发性皮肤CD8+TCLPD伴肢端定位。进一步的研究包括胸部、腹部和骨盆的CT扫描,以分期疾病。结果显示没有皮肤外受累。结论:与其他CD8+细胞毒性淋巴增生相比,准确鉴定原发性皮肤CD8+ATLPD具有明显的预后和治疗意义,因此至关重要。原发性皮肤CD8+TCLPD可以保守治疗,通常遵循缓慢的临床过程,无论治疗方法如何。了解临床情况以及形态学和免疫表型特征,有助于做出准确的诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Rare Tumors
Rare Tumors ONCOLOGY-
CiteScore
1.50
自引率
0.00%
发文量
15
审稿时长
15 weeks
期刊最新文献
The efficacy of combination immunotherapy with ipilimumab plus nivolumab in metastatic myxofibrosarcoma. Surgical management of a chest wall osteosarcoma with pleural and lung invasion through en-bloc chest resection and complex reconstruction. Case report. Exploration of the causative gene in a case of multiple nevoid basal cell carcinoma: A case report. Comprehensive study of ancient schwannoma: Exploring histomorphological diversity and diagnostic challenges. Novel MEN1-associated retroperitoneal pleomorphic liposarcoma.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1